TGN-073 is a aquaporin 4 (AQP4) modulator, as well as an orally available, blood-brain barrier-permeable agent. TGN-073 increases the uptake and distribution of brain MRI tracers in the brain parenchyma and reduces the levels of insoluble amyloid-beta 40 and beta 42. TGN-073 can be used in research related to Alzheimers disease, dementia, traumatic brain injury and pain[1][2][3].
Molekulargewicht:
340.40
Reinheit:
99.53
CAS Nummer:
[877459-36-4]
Formel:
C18H16N2O3S
Target-Kategorie:
Aquaporin
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten